Board of Directors
Stephane Ducroux
Chief Executive Officer
Stephane Ducroux brings 22 years of international experience in the Natural Specialty Ingredients industry. He is a proven senior executive that has built and led teams towards growth ambitions in a multicultural-international B2B environment. Stephane is a versatile, energetic, hands on and results oriented leader with expertise in acquisitions, integrations, cross functional management & International business development.
In former roles, Stephane was COO at Naturex Americas/Asia-Pacific (18years) & Board Director as well as PureCircle CCO & Deputy CEO.
Keith Thomson
Chief Financial Officer
Keith qualified as a Chartered Accountant with KPMG. He was COO and CFO at Phytopharm plc where he successfully re-structured the business and enabled the company to close a £25 million fundraising. He has helped guide a number of international healthcare businesses including: On Medica an international E-detailing business, Verigen, a German based multinational tissue engineering business, and Vision RT, a business utilising 3D surface imaging technology to improve the efficacy of radiotherapy treatment.
Akshat Kshetrapal
Non-executive Director
Akshat is an Investment Director at dsm-firmenich Venturing. He has spent over 15 years in the investments spanning seed, venture, growth-stage and late-stage investments across organizations such as Sequoia Capital, Gray Ghost Ventures, Max India and PGGM Private Equity.
Akshat holds a bachelor’s degree in Commerce from the University of Delhi, a MSc in Finance from University of Amsterdam, and a MBA from the Indian School of Business.
Brett Stacey
Non-executive Director
Brett Stacey has 35 years of global experience in global financial markets. He was instrumental in setting up the derivative markets in South Africa becoming Deputy Chairman of South African Stock Exchange. He was also CEO and founder of the first derivative broking company in South Africa which was ultimately sold to JP Morgan. As a member of the Johannesburg Stock Exchange he was responsible for a number of flotations and was a member of the New Products Committee.
After selling his business in South Africa he moved to the United Kingdom in 2004 and is now a partner in Regent Assay, a Corporate Finance Company which operates in the small to medium sector concentrating on sales of family businesses and raising capital for companies in a growth phase.
Brett holds an accounting degree and has an MBA from the University of Cape Town.
Contact us
